Your browser doesn't support javascript.
loading
Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.
Dubsky, P; Curigliano, G; Burstein, H J; Winer, E P; Gnant, M; Loibl, S; Colleoni, M; Regan, M M; Piccart-Gebhart, M; Senn, H-J; Thürlimann, B; André, F; Baselga, J; Bergh, J; Bonnefoi, H; Brucker, S Y; Cardoso, F; Carey, L; Ciruelos, E; Cuzick, J; Denkert, C; Di Leo, A; Ejlertsen, B; Francis, P; Galimberti, V; Garber, J; Gulluoglu, B; Goodwin, P; Harbeck, N; Hayes, D F; Huang, C-S; Huober, J; Khaled, H; Jassem, J; Jiang, Z; Karlsson, P; Morrow, M; Orecchia, R; Osborne, K C; Pagani, O; Partridge, A H; Pritchard, K; Ro, J; Rutgers, E J T; Sedlmayer, F; Semiglazov, V; Shao, Z; Smith, I; Toi, M; Tutt, A.
Afiliação
  • Dubsky P; Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Curigliano G; Klinik St. Anna, Luzern, Switzerland.
  • Burstein HJ; Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy.
  • Winer EP; Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Gnant M; Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Loibl S; Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Colleoni M; German Breast Group, Neu-Isenburg, Germany.
  • Regan MM; Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy.
  • Piccart-Gebhart M; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Senn HJ; Institut Jules Bordet, Bruxelles, Belgium.
  • Thürlimann B; Tumor and Breast Center ZeTuP, St Gallen, Switzerland.
  • Baselga J; Institut de Cancérologie Gustave Roussy, Villejuif, France.
  • Bergh J; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Bonnefoi H; Karolinska Institute and University Hospital, Stockholm, Sweden.
  • Brucker SY; University of Bordeaux, Bordeaux, France.
  • Cardoso F; Universitäts-Frauenklinik Tübingen, Tübingen, Germany.
  • Carey L; Champalimaud Cancer Centre, Lisbon, Portugal.
  • Ciruelos E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
  • Cuzick J; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Denkert C; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Di Leo A; Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Ejlertsen B; Azienda Usl Toscana Centro, Prato, Italy.
  • Francis P; Rigshospitalet, Copenhagen, Denmark.
  • Galimberti V; Peter McCallum Cancer Centre, Melbourne, Australia.
  • Garber J; Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Gulluoglu B; Klinik St. Anna, Luzern, Switzerland.
  • Goodwin P; Marmara University School of Medicine, Istanbul, Turkey.
  • Harbeck N; University of Toronto, Mount Sinai Hospital, Toronto, Canada.
  • Hayes DF; University of Munich, München, Germany.
  • Huang CS; Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA.
  • Huober J; National Taiwan University Hospital, Taipei, Taiwan.
  • Khaled H; University of Ulm, Ulm, Germany.
  • Jassem J; The National Cancer Institute, Cairo University, Cairo, Egypt.
  • Jiang Z; Medical University of Gdansk, Gdansk, Poland.
  • Karlsson P; Hospital Affiliated to Military Medical Science, Beijing, China.
  • Morrow M; Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden.
  • Orecchia R; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Osborne KC; Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Pagani O; Baylor College of Medicine, Houston, USA.
  • Partridge AH; Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
  • Pritchard K; Klinik St. Anna, Luzern, Switzerland.
  • Ro J; University of Toronto, Sunnybrook Odette Cancer Center, Toronto, Canada.
  • Rutgers EJT; National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea.
  • Sedlmayer F; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Semiglazov V; LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria.
  • Shao Z; N.N.Petrov Research Institute of Oncology, St. Petersburg, Russian Federation.
  • Smith I; Fudan University Cancer Hospital, Shanghai, China.
  • Toi M; The Royal Marsden, Sutton, Surrey, UK.
  • Tutt A; Graduate School of Medicine Kyoto University, Sakyo-ku Kyoto City, Japan.
Ann Oncol ; 29(1): 281-282, 2018 01 01.
Article em En | MEDLINE | ID: mdl-29045519
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) / Consenso Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) / Consenso Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Áustria